搜索临床试验以:IBI 389注射液
总计12752个结果
-
PharmAbcineMerck Sharp & Dohme LLC; Novotech (Australia) Pty Limited尚未招聘
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
Neurocrine Biosciences招聘中
-
Amgen完全的癌 | 癌症 | 卵巢癌 | 输卵管癌 | 实体瘤 | 肿瘤学 | 肿瘤 | 转移瘤 | 妇科恶性肿瘤比利时, 美国, 澳大利亚
-
Majanka H. Heijenbrok-Kal, PhDNetherlands Brain Foundation招聘中
-
Neurocrine Biosciences完全的
-
London North West Healthcare NHS TrustKing's College London; Queen Mary University of London完全的
-
DermBiont, Inc.Derm Research, PLLC; Northsoundderm; ClearDermatologyandAestheticsCenter终止
-
Guru P. SonpavdeQED Therapeutics, Inc.撤销膀胱癌 | 膀胱移行细胞癌 | 成纤维细胞生长因子受体
-
Chulalongkorn University未知
-
Seagen Inc.National Cancer Institute (NCI); Academic and Community Cancer Research United完全的
-
Complexo Hospitalario Universitario de A Coruña完全的
-
University of ConnecticutNational Institute of Nursing Research (NINR)完全的
-
University of MichiganCenters for Disease Control and Prevention完全的
-
George Washington UniversityStanford University; Gordon and Betty Moore Foundation; West Virginia University Research Corporation 和其他合作者完全的
-
Biotronik SE & Co. KG完全的昏厥 | 心房颤动 (AF) | 隐源性中风 | 快速性心律失常西班牙, 澳大利亚, 德国, 瑞士, 奥地利, 丹麦